Nordic and BeeKeeperAI partner to accelerate AI clinical support systems
Health and technology consulting company Nordic and BeeKeeperAI have teamed up to help expedite the use of clinical decision support…
Health and technology consulting company Nordic and BeeKeeperAI have teamed up to help expedite the use of clinical decision support…
Supernus Pharmaceuticals has said its candidate SPN-820, demonstrated a “rapid and substantial” effect in a Phase IIa trial for adults…
Transgene’s stock has dropped after a Phase II trial of its therapeutic vaccine candidate TG4001 (tipapkinogene sovacivec) failed to meet…
Roche’s spinal muscular atrophy (SMA) drug Evrysdi (risdiplam) has helped pre-symptomatic babies reach rare milestones after two years of treatment…
The rise of GLP-1 receptor agonists (GLP-1RAs) has ignited a surge in the obesity market in recent years, transforming treatment…
US company Inocras has announced the successful clinical validation of its CancerVision target enhanced whole genome sequencing (TE-WGS) technology. TE-WGS…
Clearside Biomedical’s Phase IIb ODYSSEY study of its drug-device combination CLS-AX (axitinib injectable suspension) has successfully achieved its primary and…
Purespring Therapeutics has secured £80m ($105m) to kick start a Phase I/II trial of its experimental adeno-associated viral (AAV) gene…
Gilead has presented updated data for its twice-yearly pre-exposure prophylaxis (PrEP) lenacapavir, which has shown nearly perfect efficacy in two…
The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has unveiled a new business plan to build on the launch…